SCHEMBL7960041

SCHEMBL7960041

O=S(=O)(Oc1ccccc1CC1CCCC=C1c1nc(-c2ccccc2)c(-c2ccccc2)o1)C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.56
PTGIR P43119 5/20 0.56
PTGER1 P34995 1/20 0.56
PTGER3 P43115 1/20 0.52
FABP4 P15090 2/20 0.36
FABP3 P05413 1/20 0.36
DRD2 P14416 3/20 0.33
DRD3 P35462 3/20 0.33
DRD1 P21728 1/20 0.33
DRD4 P21917 1/20 0.33
DRD5 P21918 1/20 0.33
KDM4E B2RXH2 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HTR1D P28221 2/20 0.31
PTGS2 P35354 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964160 0.92 PTGIR (0.54) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7960526 0.88 PTGIR (0.60) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7475683 0.87 PTGIR (0.62) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7959959 0.86 PTGIR (0.59) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7964274 0.85 PTGIR (0.54) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7479534 0.85 PTGIR (0.69) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7479528 0.85 PTGIR (0.69) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7949627 0.85 PTGIR (0.69) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7493935 0.85 PTGER4 (0.58) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7949681 0.83 PTGIR (0.58) PTGER4PTGIRPTGER1PTGER3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed